首页 | 本学科首页   官方微博 | 高级检索  
     

糖尿病性勃起功能障碍研究进展
引用本文:黄淑妍,陈澍,凤仪萍. 糖尿病性勃起功能障碍研究进展[J]. 中华男科学杂志, 2006, 12(2): 178-180,182
作者姓名:黄淑妍  陈澍  凤仪萍
作者单位:1. 广州医学院第二附属医院,老年病科,广东,广州,510260
2. 广州医学院第二附属医院,内分泌科,广东,广州,510260
3. 广州医学院第二附属医院,泌尿外科,广东,广州,510260
摘    要:
勃起功能障碍是糖尿病常见并发症。糖尿病性勃起功能障碍发病率为20%~75%。糖尿病引起的血管、神经病变,肌肉组织的改变导致勃起功能障碍。控制血糖、血压和血脂是糖尿病性勃起功能障碍治疗的基础。半数的糖尿病性勃起功能障碍患者用磷酸二酯酶-5抑制剂治疗有效,海绵体内注射血管活性剂有效率大于90%,阴茎假体植入手术适用于经其他治疗效果不满意的各种勃起功能障碍患者。

关 键 词:勃起功能障碍  糖尿病  发病机制  治疗
文章编号:1009-3591(2006)02-0178-04
收稿时间:2005-02-24
修稿时间:2005-02-242005-08-02

Advances in Diabetic Erectile Dysfunction
HUANG Shu-Yan,CHEN Shu,FENG Yi-Ping. Advances in Diabetic Erectile Dysfunction[J]. National journal of andrology, 2006, 12(2): 178-180,182
Authors:HUANG Shu-Yan  CHEN Shu  FENG Yi-Ping
Affiliation:1. Department of Gerontology; 2. Department of Endocrinology;3. Department of Urology, the Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guartgdong 510260, China
Abstract:
Erectile dysfunction is common complication of diabetes mellitus.The incidence of diabetes mellitus induced erectile dysfunction(DMED) is 20%~75%.DMED appears to be due to vascular-neuropathic and corpus vavernosum smooth muscular damage.To control blood glucose,blood pressure and blood lipids is the basis of DMED therapy.In 50% of the patients with DMED,the phosphodiesterase 5 inhibitors is effective,while intracavernous pharmacotherapy is effective for more than 90%.Penile prosthesis implantation continues to be the treatment of choice in case of other therapy failure.Natl J Androl,2006,12(2):178-180,182
Keywords:erectile dysfunction   diabetes mellitus    pathogenesis   therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号